Bartels K, Karhausen J, Clambey ET, Grenz A, Eltzschig HK. Perioperative organ injury. Anesthesiology. 2013;119(6):1474–89.

Article  PubMed  Google Scholar 

Writing Committee for the VSI, Devereaux PJ, Biccard BM, Sigamani A, Xavier D, Chan MTV, et al. Association of Postoperative High-Sensitivity troponin levels with myocardial Injury and 30-Day mortality among patients undergoing noncardiac surgery. JAMA. 2017;317(16):1642–51.

Article  Google Scholar 

Devereaux PJ, Szczeklik W. Myocardial injury after non-cardiac surgery: diagnosis and management. Eur Heart J. 2020;41(32):3083–91.

Article  CAS  PubMed  Google Scholar 

Ruetzler K, Smilowitz NR, Berger JS, Devereaux PJ, Maron BA, Newby LK, et al. Diagnosis and management of patients with myocardial Injury after noncardiac surgery: a Scientific Statement from the American Heart Association. Circulation. 2021;144(19):e287–305.

Article  CAS  PubMed  Google Scholar 

Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apob-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583–8.

Article  CAS  PubMed  Google Scholar 

Cai G, Liu W, Lv S, Wang X, Guo Y, Yan Z, et al. Gender-specific associations between atherogenic index of plasma and the presence and severity of acute coronary syndrome in very young adults: a hospital-based observational study. Lipids Health Dis. 2019;18(1):99.

Article  PubMed  PubMed Central  Google Scholar 

Wu TT, Gao Y, Zheng YY, Ma YT, Xie X. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis. 2018;17(1):197.

Article  PubMed  PubMed Central  Google Scholar 

Guo Q, Zhou S, Feng X, Yang J, Qiao J, Zhao Y, et al. The sensibility of the new blood lipid indicator–atherogenic index of plasma (AIP) in menopausal women with coronary artery disease. Lipids Health Dis. 2020;19(1):27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bendzala M, Sabaka P, Caprnda M, Komornikova A, Bisahova M, Baneszova R, et al. Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women: a 10-year follow-up. Wien Klin Wochenschr. 2017;129(21–22):793–8.

Article  PubMed  Google Scholar 

Si Y, Fan W, Han C, Liu J, Sun L. Atherogenic index of plasma, triglyceride-glucose index and monocyte-to-lymphocyte ratio for Predicting Subclinical Coronary Artery Disease. Am J Med Sci. 2021;362(3):285–90.

Article  PubMed  Google Scholar 

von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of Observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–9.

Article  Google Scholar 

Song P, Xu L, Xu J, Zhang HQ, Yu CX, Guan QB, et al. Atherogenic Index of Plasma is Associated with Body Fat Level in type 2 diabetes Mellitus patients. Curr Vasc Pharmacol. 2018;16(6):589–95.

Article  CAS  PubMed  Google Scholar 

Li YW, Kao TW, Chang PK, Chen WL, Wu LW. Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study. Sci Rep. 2021;11(1):9900.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Y, Shang X. Usefulness of atherogenic index of plasma for estimating reduced eGFR risk: insights from the national health and nutrition examination survey. Postgrad Med. 2021;133(3):278–85.

Article  CAS  PubMed  Google Scholar 

Yuan Y, Hu JW, Wang Y, Wang KK, Zheng WL, Chu C, et al. Association between atherogenic index of plasma and subclinical renal damage over a 12-year follow-up: Hanzhong adolescent hypertension study. Eur J Clin Nutr. 2020;74(2):278–84.

Article  CAS  PubMed  Google Scholar 

Shen SW, Lu Y, Li F, Yang CJ, Feng YB, Li HW, et al. Atherogenic index of plasma is an effective index for estimating abdominal obesity. Lipids Health Dis. 2018;17(1):11.

Article  PubMed  PubMed Central  Google Scholar 

da Silva A, Caldas APS, Hermsdorff HHM, Bersch-Ferreira AC, Torreglosa CR, Weber B, et al. Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care. Cardiovasc Diabetol. 2019;18(1):89.

Article  PubMed  PubMed Central  Google Scholar 

Jin JL, Cao YX, Wu LG, You XD, Guo YL, Wu NQ, et al. Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease. J Thorac Dis. 2018;10(11):6137–46.

Article  PubMed  PubMed Central  Google Scholar 

Novo G, Manno G, Russo R, Buccheri D, Dell’Oglio S, Morreale P, et al. Impact of insulin resistance on cardiac and vascular function. Int J Cardiol. 2016;221:1095–9.

Article  PubMed  Google Scholar 

Valentijn TM, Galal W, Tjeertes EK, Hoeks SE, Verhagen HJ, Stolker RJ. The obesity paradox in the surgical population. Surgeon. 2013;11(3):169–76.

Article  PubMed  Google Scholar 

Dobiásová M, Frohlich J. [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy]. Vnitr Lek. 2000;46(3):152–6.

PubMed  Google Scholar 

Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626–35.

Article  CAS  PubMed  Google Scholar 

Peng J, Luo F, Ruan G, Peng R, Li X. Hypertriglyceridemia and atherosclerosis. Lipids Health Dis. 2017;16(1):233.

Article  PubMed  PubMed Central  Google Scholar 

Chang W, Zhu F, Zheng H, Zhou Z, Miao P, Zhao L, et al. Glucagon-like peptide-1 receptor agonist dulaglutide prevents ox-LDL-induced adhesion of monocytes to human endothelial cells: an implication in the treatment of atherosclerosis. Mol Immunol. 2019;116:73–9.

Article  CAS  PubMed  Google Scholar 

Reiche ME, den Toom M, Willemsen L, van Os B, Gijbels MJJ, Gerdes N, et al. Deficiency of T cell CD40L has minor beneficial effects on obesity-induced metabolic dysfunction. BMJ Open Diabetes Res Care. 2019;7(1):e000829.

Article  PubMed  PubMed Central  Google Scholar 

Wong NKP, Nicholls SJ, Tan JTM, Bursill CA. The role of high-density lipoproteins in diabetes and its vascular complications. Int J Mol Sci. 2018;19(6).

Poti F, Simoni M, Nofer JR. Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P). Cardiovasc Res. 2014;103(3):395–404.

Article  CAS  PubMed  Google Scholar 

Farmer JA, Gotto AM. Jr. Dyslipidemia and the vulnerable plaque. Prog Cardiovasc Dis. 2002;44(6):415–28.

Article  CAS  PubMed  Google Scholar 

Cure E, Cumhur Cure M. Comment on the relationship between atherogenic index of plasma and no–reflow in patients with acute ST–segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. Int J Cardiovasc Imaging. 2020;36(5):797–8.

Article  PubMed  Google Scholar 

Sharma P, Purohit P, Gupta R. Cardiac risk factors in descendants of parents with history of coronary artery disease (CAD): an evaluation focusing on small dense low density lipoprotein cholesterol (sdLDLc) and high density lipoprotein cholesterol (HDLc). Indian J Biochem Biophys. 2013;50(5):453–61.

CAS  PubMed  Google Scholar 

Nishikura T, Koba S, Yokota Y, Hirano T, Tsunoda F, Shoji M, et al. Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery disease. J Atheroscler Thromb. 2014;21(8):755–67.

Article  PubMed  Google Scholar 

Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation. 1997;95(1):69–75.

Article  CAS  PubMed